BAD (CT-1) is a C-terminal peptide used to map regulatory surfaces that modulate protein-protein interactions within apoptotic pathways. Its amino acid composition favors amphipathic helix formation. The peptide is applied in binding assays and structural motif analysis. Applications include biophysical modeling and helix-interface research.
CAT No: B02009
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.